“…3,4). Different human malignancies have already been investigated using the Ki-67 immunohistochemistry [1,2,15,27,29,30,32,33,34,35]: The in vivo proliferation rate of RCC is low, only ranging up to 25% [15,36]. Because of this low proliferative potential, only a few mitotic cells can be obtained by biopsy.…”